KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Operating Margin (2016 - 2025)

Eli Lilly (LLY) has disclosed Operating Margin for 17 consecutive years, with 46.15% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Margin rose 671.0% year-over-year to 46.15%, compared with a TTM value of 44.82% through Dec 2025, up 890.0%, and an annual FY2025 reading of 44.82%, up 890.0% over the prior year.
  • Operating Margin was 46.15% for Q4 2025 at Eli Lilly, up from 45.57% in the prior quarter.
  • Across five years, Operating Margin topped out at 46.15% in Q4 2025 and bottomed at 21.19% in Q2 2021.
  • Average Operating Margin over 5 years is 32.63%, with a median of 31.29% recorded in 2021.
  • The sharpest move saw Operating Margin crashed -993bps in 2023, then skyrocketed 1150bps in 2025.
  • Year by year, Operating Margin stood at 29.86% in 2021, then dropped by -5bps to 28.44% in 2022, then rose by 13bps to 32.18% in 2023, then rose by 23bps to 39.44% in 2024, then increased by 17bps to 46.15% in 2025.
  • Business Quant data shows Operating Margin for LLY at 46.15% in Q4 2025, 45.57% in Q3 2025, and 45.13% in Q2 2025.